Similarly, CRCs were found to abrogate c-Myc expression in BXPC3 and capan-2 pancreatic adenocarcinoma cells and Y-79 and WERI-Rb-1 human retinoblastoma cells [141,191]. This evidence concerns the gene MYC and pancreatic adenocarcinoma.